OpenURL Connection Search

Select item for more details and to access through your institution.

CECs and IL-8 have prognostic and predictive utility in patients with recurrent platinum-sensitive ovarian cancer: biomarker correlates from the randomized phase-2 trial of olaparib and cediranib compared with olaparib in recurrent platinum-sensitive ovarian cancer
Published in:
Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00123
By:
- Lee, Jung-Min;
- Trepel, Jane B.;
- Choyke, Peter;
- Cao, Liang;
- Sissung, Tristan;
- Houston, Nicole;
- Yu, Minshu;
- Figg, William D.;
- Turkbey, Ismail Baris;
- Steinberg, Seth M.;
- Min-Jung Lee;
- Ivy, S. Percy;
- Liu, Joyce F.;
- Matulonis, Ursula A.;
- Kohn, Elise C.;
- Ford, James M.
Publication type:
Article
Treatment of Recurrent Platinum-Sensitive Epithelial Ovarian Cancer.
Published in:
European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 2, p. 71
By:
- Liu, Joyce F.;
- Matulonis, Ursula A.
Publication type:
Article
A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer.
Published in:
Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25904-w
By:
- Konstantinopoulos, Panagiotis A.;
- da Costa, Alexandre André B. A.;
- Gulhan, Doga;
- Lee, Elizabeth K.;
- Cheng, Su-Chun;
- Hendrickson, Andrea E. Wahner;
- Kochupurakkal, Bose;
- Kolin, David L.;
- Kohn, Elise C.;
- Liu, Joyce F.;
- Stover, Elizabeth H.;
- Curtis, Jennifer;
- Tayob, Nabihah;
- Polak, Madeline;
- Chowdhury, Dipanjan;
- Matulonis, Ursula A.;
- Färkkilä, Anniina;
- D'Andrea, Alan D.;
- Shapiro, Geoffrey I.
Publication type:
Article
Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient TP53 Mutant Uterine Carcinomas Is Linked to the Summation of LKB1–AKT–p53 Interactions.
Published in:
Cancers, 2021, v. 13, n. 9, p. 2195, doi. 10.3390/cancers13092195
By:
- Lynch, Katherine N.;
- Liu, Joyce F.;
- Kesten, Nikolas;
- Chow, Kin-Hoe;
- Shetty, Aniket;
- He, Ruiyang;
- Afreen, Mosammat Faria;
- Yuan, Liping;
- Matulonis, Ursula A.;
- Growdon, Whitfield B.;
- Muto, Michael G.;
- Horowitz, Neil S.;
- Feltmate, Colleen M.;
- Worley Jr., Michael J.;
- Berkowitz, Ross S.;
- Crum, Christopher P.;
- Rueda, Bo R.;
- Hill, Sarah J.;
- Horikawa, Izumi
Publication type:
Article
Uterine Serous Carcinoma and Uterine Carcinosarcoma: Molecular Features, Clinical Advances, and Emerging Therapies.
Published in:
Clinical Advances in Hematology & Oncology, 2024, v. 22, n. 6, p. 301
By:
- Lee, Elizabeth K.;
- Liu, Joyce F.
Publication type:
Article
Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment.
Published in:
Science Translational Medicine, 2016, v. 8, n. 329, p. 1, doi. 10.1126/scitranslmed.aad5653
By:
- Suming Wang;
- Blois, Anna;
- El Rayes, Tina;
- Liu, Joyce F.;
- Hirsch, Michelle S.;
- Gravdal, Karsten;
- Palakurthi, Sangeetha;
- Bielenberg, Diane R.;
- Akslen, Lars A.;
- Drapkin, Ronny;
- Mittal, Vivek;
- Watnick, Randolph S.
Publication type:
Article
Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4.
Published in:
Science Translational Medicine, 2012, v. 4, n. 147, p. 1, doi. 10.1126/scitranslmed.3003778
By:
- Yin Ren;
- Hiu Wing Cheung;
- von Maltzhan, Geoffrey;
- Agrawal, Amit;
- Cowley, Glenn S.;
- Weir, Barbara A.;
- Boehm, Jesse S.;
- Tamayo, Pablo;
- Karst, Alison M.;
- Liu, Joyce F.;
- Hirsch, Michelle S.;
- Mesirov, Jill P.;
- Drapkin, Ronny;
- Root, David E.;
- Lo, Justin;
- Fogal, Valentina;
- Ruoslahti, Erkki;
- Hahn, William C.;
- Bhatia, Sangeeta N.
Publication type:
Article
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours.
Published in:
British Journal of Cancer, 2022, v. 126, n. 7, p. 1027, doi. 10.1038/s41416-021-01664-8
By:
- Konstantinopoulos, Panagiotis A.;
- Cheng, Su-Chun;
- Supko, Jeffrey G.;
- Polak, Madeline;
- Wahner-Hendrickson, Andrea E.;
- Ivy, S. Percy;
- Bowes, Brittany;
- Sawyer, Hannah;
- Basada, Patrice;
- Hayes, Martin;
- Curtis, Jennifer;
- Horowitz, Neil;
- Wright, Alexi A.;
- Campos, Susana M.;
- Ivanova, Elena V.;
- Paweletz, Cloud P.;
- Palakurthi, Sangeetha;
- Liu, Joyce F.;
- D'Andrea, Alan D.;
- Gokhale, Prafulla C.
Publication type:
Article
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours.
Published in:
2022
By:
- Konstantinopoulos, Panagiotis A;
- Cheng, Su-Chun;
- Supko, Jeffrey G;
- Polak, Madeline;
- Wahner-Hendrickson, Andrea E;
- Ivy, S Percy;
- Bowes, Brittany;
- Sawyer, Hannah;
- Basada, Patrice;
- Hayes, Martin;
- Curtis, Jennifer;
- Horowitz, Neil;
- Wright, Alexi A;
- Campos, Susana M;
- Ivanova, Elena V;
- Paweletz, Cloud P;
- Palakurthi, Sangeetha;
- Liu, Joyce F;
- D'Andrea, Alan D;
- Gokhale, Prafulla C
Publication type:
journal article
Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response.
Published in:
Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00263-7
By:
- Zervantonakis, Ioannis K.;
- Iavarone, Claudia;
- Hsing-Yu Chen;
- Selfors, Laura M.;
- Palakurthi, Sangeetha;
- Liu, Joyce F.;
- Drapkin, Ronny;
- Matulonis, Ursula;
- Leverson, Joel D.;
- Sampath, Deepak;
- Mills, Gordon B.;
- Brugge, Joan S.
Publication type:
Article
One fixed dosing of a poly(adenosine diphosphate ribose) polymerase inhibitor does not fit all.
Published in:
Cancer (0008543X), 2023, v. 129, n. 12, p. 1795, doi. 10.1002/cncr.34705
By:
- Lee, Jung‐Min;
- Liu, Joyce F.
Publication type:
Article

Found: 11